首页 > 最新文献

Pharmacological Research - Modern Chinese Medicine最新文献

英文 中文
Pharmacological relevance of anthocyanin derivative: A review
Pub Date : 2024-12-14 DOI: 10.1016/j.prmcm.2024.100565
Pavithra Bharathy , Punniyakoti V. Thanikachalam

Background

Anthocyanins, a group of natural flavonoid pigments responsible for red, purple, and blue hues in plants, are valued in Traditional Chinese Medicine (TCM) for their health benefits including antioxidant, anti-inflammatory, and organ-protective effects.

Objective

This review explores the pharmacological properties of anthocyanins in relation to TCM applications, focusing on their antioxidant, anti-inflammatory, cardioprotective, neuroprotective, anticancer, metabolic, and skin health effects. Additionally, it highlights the challenges with bioavailability and strategies to enhance absorption.

Methods

A systematic literature review was conducted across PubMed, Scopus, and Web of Science, examining studies on anthocyanin chemistry and therapeutic applications aligned with TCM principles.

Results

Anthocyanins display structural diversity, which contributes to their wide-ranging bioactivity. Cyanidine, delphinidine and rutinoside compounds serve as potent antioxidants, reduce inflammation, support cardiovascular and neuroprotection, inhibit cancer cell growth, improve metabolic profiles, and protect skin from damage. However, the limited bioavailability of peonidin, pelargonidin, and malvidin hinders their full therapeutic potential.

Discussion

This review highlights the diverse therapeutic potential of cyanidine and delphinidine, in alignment with Traditional Chinese Medicine principles to enhance vitality and support healing. Their antioxidant, anti-inflammatory, cardioprotective, neuroprotective, anticancer, and metabolic benefits suggest that they may play a key role in managing chronic diseases. Although challenges in bioavailability remain, strategies such as encapsulation and co-ingestion show promise in improving efficacy. Future research should focus on clarifying the molecular mechanisms, optimizing formulations, and exploring interactions with the gut microbiota to fully realize their therapeutic potential.
{"title":"Pharmacological relevance of anthocyanin derivative: A review","authors":"Pavithra Bharathy ,&nbsp;Punniyakoti V. Thanikachalam","doi":"10.1016/j.prmcm.2024.100565","DOIUrl":"10.1016/j.prmcm.2024.100565","url":null,"abstract":"<div><h3>Background</h3><div>Anthocyanins, a group of natural flavonoid pigments responsible for red, purple, and blue hues in plants, are valued in Traditional Chinese Medicine (TCM) for their health benefits including antioxidant, anti-inflammatory, and organ-protective effects.</div></div><div><h3>Objective</h3><div>This review explores the pharmacological properties of anthocyanins in relation to TCM applications, focusing on their antioxidant, anti-inflammatory, cardioprotective, neuroprotective, anticancer, metabolic, and skin health effects. Additionally, it highlights the challenges with bioavailability and strategies to enhance absorption.</div></div><div><h3>Methods</h3><div>A systematic literature review was conducted across PubMed, Scopus, and Web of Science, examining studies on anthocyanin chemistry and therapeutic applications aligned with TCM principles.</div></div><div><h3>Results</h3><div>Anthocyanins display structural diversity, which contributes to their wide-ranging bioactivity. Cyanidine, delphinidine and rutinoside compounds serve as potent antioxidants, reduce inflammation, support cardiovascular and neuroprotection, inhibit cancer cell growth, improve metabolic profiles, and protect skin from damage. However, the limited bioavailability of peonidin, pelargonidin, and malvidin hinders their full therapeutic potential.</div></div><div><h3>Discussion</h3><div>This review highlights the diverse therapeutic potential of cyanidine and delphinidine, in alignment with Traditional Chinese Medicine principles to enhance vitality and support healing. Their antioxidant, anti-inflammatory, cardioprotective, neuroprotective, anticancer, and metabolic benefits suggest that they may play a key role in managing chronic diseases. Although challenges in bioavailability remain, strategies such as encapsulation and co-ingestion show promise in improving efficacy. Future research should focus on clarifying the molecular mechanisms, optimizing formulations, and exploring interactions with the gut microbiota to fully realize their therapeutic potential.</div></div>","PeriodicalId":101013,"journal":{"name":"Pharmacological Research - Modern Chinese Medicine","volume":"14 ","pages":"Article 100565"},"PeriodicalIF":0.0,"publicationDate":"2024-12-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143138016","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
TCMNP: A data processing and visualization database and R package for traditional Chinese medicine network pharmacology
Pub Date : 2024-12-14 DOI: 10.1016/j.prmcm.2024.100562
Min Ying , Jing Feng , Mei Liu , Lijuan Wang , Jinkun Liu

Background

Network pharmacology has become crucial for elucidating the mechanisms underlying traditional Chinese medicine (TCM). However, challenges persist in processing and visualizing complex data related to TCM network pharmacology (TCMNP). To address this, we developed ''TCMNP'', a specialized database and R package within the R environment, aimed at enhancing data processing and visualization capabilities for TCM research.

Methods

''TCMNP'' integrates data from prominent databases, including DrugBank, TCMSP, ETCM, DisGeNET, and OMIM, to establish a comprehensive relational framework connecting TCM prescriptions, medicinal materials, bioactive ingredients, therapeutic targets, and associated diseases. Leveraging packages such as ''dplyr'', ''clusterProfiler'', ''ggplot2'', and ''circlize'', we created a suite of functions that facilitate streamlined data analysis and advanced visualizations within R.

Results

''TCMNP'' supports comprehensive analysis and visualization workflows for TCM compounds, individual herbs, active ingredients, molecular targets, and biological pathways. The database comprises 571 TCM herbs, 17,118 unique ingredients, 10,013 diseases, and 15,956 targets, enabling automated processes from compound component screening to target and pathway enrichment analysis. Additional features include protein-protein interaction mapping and transcription factor-gene target analysis, complemented by a user-friendly interface for generating TCM network pharmacology visualizations. ''TCMNP'' is accessible at https://tcmlab.com.cn/tcmnp, and the package available at https://github.com/tcmlab/TCMNP.

Conclusion

''TCMNP'' database and package provide user-friendly visualization tools for analyzing the components of TCM formulas and their potential therapeutic effects on diseases. We anticipate that ''TCMNP'' will help to explore the mechanism of TCM to treat diseases.
{"title":"TCMNP: A data processing and visualization database and R package for traditional Chinese medicine network pharmacology","authors":"Min Ying ,&nbsp;Jing Feng ,&nbsp;Mei Liu ,&nbsp;Lijuan Wang ,&nbsp;Jinkun Liu","doi":"10.1016/j.prmcm.2024.100562","DOIUrl":"10.1016/j.prmcm.2024.100562","url":null,"abstract":"<div><h3>Background</h3><div>Network pharmacology has become crucial for elucidating the mechanisms underlying traditional Chinese medicine (TCM). However, challenges persist in processing and visualizing complex data related to TCM network pharmacology (TCMNP). To address this, we developed ''TCMNP'', a specialized database and R package within the R environment, aimed at enhancing data processing and visualization capabilities for TCM research.</div></div><div><h3>Methods</h3><div>''TCMNP'' integrates data from prominent databases, including DrugBank, TCMSP, ETCM, DisGeNET, and OMIM, to establish a comprehensive relational framework connecting TCM prescriptions, medicinal materials, bioactive ingredients, therapeutic targets, and associated diseases. Leveraging packages such as ''dplyr'', ''clusterProfiler'', ''ggplot2'', and ''circlize'', we created a suite of functions that facilitate streamlined data analysis and advanced visualizations within R.</div></div><div><h3>Results</h3><div>''TCMNP'' supports comprehensive analysis and visualization workflows for TCM compounds, individual herbs, active ingredients, molecular targets, and biological pathways. The database comprises 571 TCM herbs, 17,118 unique ingredients, 10,013 diseases, and 15,956 targets, enabling automated processes from compound component screening to target and pathway enrichment analysis. Additional features include protein-protein interaction mapping and transcription factor-gene target analysis, complemented by a user-friendly interface for generating TCM network pharmacology visualizations. ''TCMNP'' is accessible at <span><span>https://tcmlab.com.cn/tcmnp</span><svg><path></path></svg></span>, and the package available at <span><span>https://github.com/tcmlab/TCMNP</span><svg><path></path></svg></span>.</div></div><div><h3>Conclusion</h3><div>''TCMNP'' database and package provide user-friendly visualization tools for analyzing the components of TCM formulas and their potential therapeutic effects on diseases. We anticipate that ''TCMNP'' will help to explore the mechanism of TCM to treat diseases.</div></div>","PeriodicalId":101013,"journal":{"name":"Pharmacological Research - Modern Chinese Medicine","volume":"14 ","pages":"Article 100562"},"PeriodicalIF":0.0,"publicationDate":"2024-12-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143137974","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ginger (Zingiber officinale) in traditional Chinese medicine: A comprehensive review of its anti-inflammatory properties and clinical applications
Pub Date : 2024-12-14 DOI: 10.1016/j.prmcm.2024.100561
Jitendra Gupta , Bhawna Sharma , Rahul Sorout , Ram Gopal Singh , Ittishree , Mukesh Chandra Sharma

Introduction

Traditional Chinese medicine (TCM) has widely used ginger (Zingiber officinale) for its anti-inflammatory properties and various clinical applications. This comprehensive review aims to explore the phytochemical properties of ginger, focusing on its antioxidant components and active ingredients such as shogaols, gingerols, and zingerone. The unique composition of ginger, includes terpenoids, flavonoids, and volatile oils, contributes to its therapeutic potential in managing various health conditions.

Methodology

We conducted a thorough examination of existing literature to gather information on the anti-inflammatory properties and clinical applications of ginger on conditions like osteoarthritis, rheumatoid arthritis, irritable bowel syndrome, and asthma to gain insights into its efficacy and mechanisms of action. We also focused on studies reporting on the phytochemical composition of ginger, including its antioxidant compounds and active ingredients, to understand how these components contribute to its therapeutic effects.

Results

The review revealed that ginger possesses antioxidant properties attributed to compounds like shogaols, gingerols, and zingerone. Additionally, the terpenoids, flavonoids, and volatile oils found in ginger play a crucial role in its anti-inflammatory and health-promoting effects. Furthermore, studies have shown that supplementing with ginger can improve lung function and mitigate airway inflammation in asthma patients.

Conclusion

Ginger emerges as a valuable botanical remedy in TCM due to its diverse phytochemical profile and therapeutic properties. The antioxidant components and active ingredients present in ginger contribute to its anti-inflammatory effects and clinical applications in managing various health conditions. We need to conduct further research and clinical trials to fully explore the potential of ginger for promoting health and well-being.
{"title":"Ginger (Zingiber officinale) in traditional Chinese medicine: A comprehensive review of its anti-inflammatory properties and clinical applications","authors":"Jitendra Gupta ,&nbsp;Bhawna Sharma ,&nbsp;Rahul Sorout ,&nbsp;Ram Gopal Singh ,&nbsp;Ittishree ,&nbsp;Mukesh Chandra Sharma","doi":"10.1016/j.prmcm.2024.100561","DOIUrl":"10.1016/j.prmcm.2024.100561","url":null,"abstract":"<div><h3>Introduction</h3><div>Traditional Chinese medicine (TCM) has widely used ginger (<em>Zingiber officinale</em>) for its anti-inflammatory properties and various clinical applications. This comprehensive review aims to explore the phytochemical properties of ginger, focusing on its antioxidant components and active ingredients such as shogaols, gingerols, and zingerone. The unique composition of ginger, includes terpenoids, flavonoids, and volatile oils, contributes to its therapeutic potential in managing various health conditions.</div></div><div><h3>Methodology</h3><div>We conducted a thorough examination of existing literature to gather information on the anti-inflammatory properties and clinical applications of ginger on conditions like osteoarthritis, rheumatoid arthritis, irritable bowel syndrome, and asthma to gain insights into its efficacy and mechanisms of action. We also focused on studies reporting on the phytochemical composition of ginger, including its antioxidant compounds and active ingredients, to understand how these components contribute to its therapeutic effects.</div></div><div><h3>Results</h3><div>The review revealed that ginger possesses antioxidant properties attributed to compounds like shogaols, gingerols, and zingerone. Additionally, the terpenoids, flavonoids, and volatile oils found in ginger play a crucial role in its anti-inflammatory and health-promoting effects. Furthermore, studies have shown that supplementing with ginger can improve lung function and mitigate airway inflammation in asthma patients.</div></div><div><h3>Conclusion</h3><div>Ginger emerges as a valuable botanical remedy in TCM due to its diverse phytochemical profile and therapeutic properties. The antioxidant components and active ingredients present in ginger contribute to its anti-inflammatory effects and clinical applications in managing various health conditions. We need to conduct further research and clinical trials to fully explore the potential of ginger for promoting health and well-being.</div></div>","PeriodicalId":101013,"journal":{"name":"Pharmacological Research - Modern Chinese Medicine","volume":"14 ","pages":"Article 100561"},"PeriodicalIF":0.0,"publicationDate":"2024-12-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143137978","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Qiangyang decoction attenuates ischemia/reperfusion-induced cardiomyocyte ferroptosis via ULK1/KEAP1/Nrf2 axis
Pub Date : 2024-12-12 DOI: 10.1016/j.prmcm.2024.100560
Jing Wang , Wan Cai , Jingxuan Chen , Wenjin Wang , Wentao Fu , Wen Ge , Hao Chi

Background

Myocardial ischemia-reperfusion (I/R) induced cardiomyocyte death is a major cause of cardiac dysfunction and fibrosis. Ferroptosis of cardiomyocytes has been demonstrated to contribute to I/R induced injury. Qiangyang decoction (QYD) is commonly used in clinical treatment of hypertension and cardiac fibrosis. However, the intervention effect of QYD on I/R injury, especially its therapeutic efficacy on ferroptosis in cardiomyocytes, remains unclear. This study aimed to investigate the effect of QYD against I/R induced cardiomyocyte ferroptosis and to reveal the underlying mechanism.

Methods

In this study, UPLC-MS/MS was conducted to identify the component of QYD. An in vivo I/R mouse model and an in vitro cardiomyocytes OGD model were utilized to evaluate the cardiac protective effect of QYD. Transcriptome analysis and western blotting assays were used to explore the mechanism.

Results

A high dose of QYD exerts a cardioprotective effect through inhibiting I/R-induced cardiomyocyte ferroptosis. A high dose of QYD ameliorated I/R and OGD injury; these beneficial effects were not further enhanced by the ferroptosis inhibitor Fer-1. Anti-ferroptosis factors FPN1, Homx1, and GPX4 were transcriptionally upregulated by QYD both in mouse heart and adult mouse cardiomyocytes (AMCMs). Consistently, the kelch like ECH associated protein 1 (KEAP1) level and nuclear factor erythroid 2-related factor 2 (Nrf2) degradation were remarkably suppressed. RNA-sequencing results revealed that unc-51 like autophagy activating kinase 1 (ULK1), a serine kinase mediating the autophagy-dependent degradation of KEAP1, was significantly up-regulated in QYD-treated mouse hearts. The ULK1 inhibitor SBI-0206965 abolished the inhibition of QYD on KEAP1 and notably weakened the cardiac protective effect.

Conclusions

These findings suggest that QYD exerted cardiac protection by activating ULK1 and subsequently inhibited KEAP1, thereby enhancing Nrf2 level and initiating the transcription of ferroptosis-resistance genes. These findings highlight that QYD may serve as a cardioprotective strategy for I/R.
{"title":"Qiangyang decoction attenuates ischemia/reperfusion-induced cardiomyocyte ferroptosis via ULK1/KEAP1/Nrf2 axis","authors":"Jing Wang ,&nbsp;Wan Cai ,&nbsp;Jingxuan Chen ,&nbsp;Wenjin Wang ,&nbsp;Wentao Fu ,&nbsp;Wen Ge ,&nbsp;Hao Chi","doi":"10.1016/j.prmcm.2024.100560","DOIUrl":"10.1016/j.prmcm.2024.100560","url":null,"abstract":"<div><h3>Background</h3><div>Myocardial ischemia-reperfusion (I/R) induced cardiomyocyte death is a major cause of cardiac dysfunction and fibrosis. Ferroptosis of cardiomyocytes has been demonstrated to contribute to I/R induced injury. Qiangyang decoction (QYD) is commonly used in clinical treatment of hypertension and cardiac fibrosis. However, the intervention effect of QYD on I/R injury, especially its therapeutic efficacy on ferroptosis in cardiomyocytes, remains unclear. This study aimed to investigate the effect of QYD against I/R induced cardiomyocyte ferroptosis and to reveal the underlying mechanism.</div></div><div><h3>Methods</h3><div>In this study, UPLC-MS/MS was conducted to identify the component of QYD. An in vivo I/R mouse model and an in vitro cardiomyocytes OGD model were utilized to evaluate the cardiac protective effect of QYD. Transcriptome analysis and western blotting assays were used to explore the mechanism.</div></div><div><h3>Results</h3><div>A high dose of QYD exerts a cardioprotective effect through inhibiting I/R-induced cardiomyocyte ferroptosis. A high dose of QYD ameliorated I/R and OGD injury; these beneficial effects were not further enhanced by the ferroptosis inhibitor Fer-1. Anti-ferroptosis factors FPN1, Homx1, and GPX4 were transcriptionally upregulated by QYD both in mouse heart and adult mouse cardiomyocytes (AMCMs). Consistently, the kelch like ECH associated protein 1 (KEAP1) level and nuclear factor erythroid 2-related factor 2 (Nrf2) degradation were remarkably suppressed. RNA-sequencing results revealed that unc-51 like autophagy activating kinase 1 (ULK1), a serine kinase mediating the autophagy-dependent degradation of KEAP1, was significantly up-regulated in QYD-treated mouse hearts. The ULK1 inhibitor SBI-0206965 abolished the inhibition of QYD on KEAP1 and notably weakened the cardiac protective effect.</div></div><div><h3>Conclusions</h3><div>These findings suggest that QYD exerted cardiac protection by activating ULK1 and subsequently inhibited KEAP1, thereby enhancing Nrf2 level and initiating the transcription of ferroptosis-resistance genes. These findings highlight that QYD may serve as a cardioprotective strategy for I/R.</div></div>","PeriodicalId":101013,"journal":{"name":"Pharmacological Research - Modern Chinese Medicine","volume":"14 ","pages":"Article 100560"},"PeriodicalIF":0.0,"publicationDate":"2024-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143137973","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Jinxinkang granule alleviates chronic heart failure by enhancing GPER/AMPK/PCG-1α-mediated fatty acid oxidation
Pub Date : 2024-12-10 DOI: 10.1016/j.prmcm.2024.100556
Haixiang Zhong , Liu He , Wanru Zhong , Lili Wang , Jianmin Luo , Qi Chen , Rong Li , Rong Zhang , Zhongqiu Liu , Yuanyuan Cheng

Introduction

Chronic heart failure (CHF) is considered to be the last battlefield of cardiovascular disease. Jinxinkang granule (JXK) is an integrated traditional Chinese medicine formula for treating CHF. Our previous clinical study showed that JXK could increase the left ventricular ejection fraction and reduce concomitant symptoms in patients with CHF. However, the molecular mechanism underlying the action of JXK on CHF has yet to be fully illustrated.

Methods

Sprague-Dawley (SD) rats under left anterior descending artery ligation model, C57BL/6 mice subcutaneously injected isoproterenol (ISO) model in vivo and H9c2 cells under oxygen glucose deprivation (OGD) in vitro were used to evaluate the effect of JXK against CHF. Cardiac function and morphology assessment using M-mode echocardiography, H&E/Masson/WGA staining, western blotting analysis, real-time PCR detection, ATP and cAMP assays were used to explore the mechanism of JXK against CHF.

Results

JXK improved cardiac function and ameliorated cardiac fibrosis in both LAD-induced CHF rats and ISO-induced CHF mice, and protected cardiomyocytes from OGD injury in H9c2 cells. Moreover, JXK increased the level of ATP content and enhanced fatty acid oxidation by increasing CD36, CPT1A and ACADM expression. Mechanism study showed that JXK increased the GPER expression and cAMP level, promoted AMPK phosphorylation and PGC-1α expression. Additionally, molecular docking analysis showed that dihydroisotanshinone I has a high binding affinity with GPER at -8.5 kcal/mol, which has the similar binding sites with G-1, a GPER agonist. Importantly, after using the inhibitor of GPER (G15), the cardioprotective effect of JXK and the enhancing effect on the fatty acid oxidation were blocked.

Conclusion

JXK effectively activated GPER/AMPK/PGC-1α signaling pathway to enhance the oxidation of fatty acid, thereby promoting cardiac energy metabolism production to ameliorate CHF.
{"title":"Jinxinkang granule alleviates chronic heart failure by enhancing GPER/AMPK/PCG-1α-mediated fatty acid oxidation","authors":"Haixiang Zhong ,&nbsp;Liu He ,&nbsp;Wanru Zhong ,&nbsp;Lili Wang ,&nbsp;Jianmin Luo ,&nbsp;Qi Chen ,&nbsp;Rong Li ,&nbsp;Rong Zhang ,&nbsp;Zhongqiu Liu ,&nbsp;Yuanyuan Cheng","doi":"10.1016/j.prmcm.2024.100556","DOIUrl":"10.1016/j.prmcm.2024.100556","url":null,"abstract":"<div><h3>Introduction</h3><div>Chronic heart failure (CHF) is considered to be the last battlefield of cardiovascular disease. Jinxinkang granule (JXK) is an integrated traditional Chinese medicine formula for treating CHF. Our previous clinical study showed that JXK could increase the left ventricular ejection fraction and reduce concomitant symptoms in patients with CHF. However, the molecular mechanism underlying the action of JXK on CHF has yet to be fully illustrated.</div></div><div><h3>Methods</h3><div>Sprague-Dawley (SD) rats under left anterior descending artery ligation model, C57BL/6 mice subcutaneously injected isoproterenol (ISO) model in vivo and H9c2 cells under oxygen glucose deprivation (OGD) in vitro were used to evaluate the effect of JXK against CHF. Cardiac function and morphology assessment using M-mode echocardiography, H&amp;E/Masson/WGA staining, western blotting analysis, real-time PCR detection, ATP and cAMP assays were used to explore the mechanism of JXK against CHF.</div></div><div><h3>Results</h3><div>JXK improved cardiac function and ameliorated cardiac fibrosis in both LAD-induced CHF rats and ISO-induced CHF mice, and protected cardiomyocytes from OGD injury in H9c2 cells. Moreover, JXK increased the level of ATP content and enhanced fatty acid oxidation by increasing CD36, CPT1A and ACADM expression. Mechanism study showed that JXK increased the GPER expression and cAMP level, promoted AMPK phosphorylation and PGC-1α expression. Additionally, molecular docking analysis showed that dihydroisotanshinone I has a high binding affinity with GPER at -8.5 kcal/mol, which has the similar binding sites with G-1, a GPER agonist. Importantly, after using the inhibitor of GPER (G15), the cardioprotective effect of JXK and the enhancing effect on the fatty acid oxidation were blocked.</div></div><div><h3>Conclusion</h3><div>JXK effectively activated GPER/AMPK/PGC-1α signaling pathway to enhance the oxidation of fatty acid, thereby promoting cardiac energy metabolism production to ameliorate CHF.</div></div>","PeriodicalId":101013,"journal":{"name":"Pharmacological Research - Modern Chinese Medicine","volume":"14 ","pages":"Article 100556"},"PeriodicalIF":0.0,"publicationDate":"2024-12-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143137975","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Harnessing Traditional Chinese Medicine for myopathy: A comprehensive review of herbal therapeutics
Pub Date : 2024-12-08 DOI: 10.1016/j.prmcm.2024.100557
Aswini Rajendran , Veronica Elumalai , Palanirajan Vijayaraj Kumar , Karthikeyan Elumalai

Introduction

Myopathy, a group of conditions affecting muscles, is characterized by muscle weakness and degeneration, resulting in reduced quality of life. While existing treatments primarily address symptoms, they often fail to target underlying causes and may produce adverse effects. Traditional Chinese Medicine (TCM) offers a promising alternative through its herbal remedies, which aim to enhance muscle function, reduce inflammation, and promote cellular repair.

Methods

This review investigates the current literature on Traditional Chinese Medicine (TCM) in the treatment of myopathy. Our analysis focused on particular herbs, such as Astragalus (Huang Qi), Ginseng (Ren Shen), and Angelica sinensis (Dang Gui), as well as herbal combinations like Bu Yang Huan Wu Tang. Through an evaluation of pharmacological research, clinical case studies, and controlled trials, we obtained valuable information regarding the therapeutic mechanisms and clinical efficacy of these TCM approaches.

Results

Studies highlight the ability of Traditional Chinese Medicine (TCM) herbs to protect and restore muscles through their anti-inflammatory, antioxidant, and metabolic regulatory properties. Investigations have demonstrated improvements in muscle strength, function, and patient outcomes. TCM showed potential supplementary benefits when integrated with standard medical approaches.

Discussion

Traditional Chinese Medicine (TCM) offers a comprehensive strategy for addressing myopathy, showing encouraging outcomes in enhancing muscle function and patient well-being. However, despite its potential benefits, there are still obstacles to overcome regarding consistency, risk management, and scientific verification. Additional studies are required to effectively incorporate TCM into established treatment protocols.
{"title":"Harnessing Traditional Chinese Medicine for myopathy: A comprehensive review of herbal therapeutics","authors":"Aswini Rajendran ,&nbsp;Veronica Elumalai ,&nbsp;Palanirajan Vijayaraj Kumar ,&nbsp;Karthikeyan Elumalai","doi":"10.1016/j.prmcm.2024.100557","DOIUrl":"10.1016/j.prmcm.2024.100557","url":null,"abstract":"<div><h3>Introduction</h3><div>Myopathy, a group of conditions affecting muscles, is characterized by muscle weakness and degeneration, resulting in reduced quality of life. While existing treatments primarily address symptoms, they often fail to target underlying causes and may produce adverse effects. Traditional Chinese Medicine (TCM) offers a promising alternative through its herbal remedies, which aim to enhance muscle function, reduce inflammation, and promote cellular repair.</div></div><div><h3>Methods</h3><div>This review investigates the current literature on Traditional Chinese Medicine (TCM) in the treatment of myopathy. Our analysis focused on particular herbs, such as Astragalus (Huang Qi), Ginseng (Ren Shen), and Angelica sinensis (Dang Gui), as well as herbal combinations like Bu Yang Huan Wu Tang. Through an evaluation of pharmacological research, clinical case studies, and controlled trials, we obtained valuable information regarding the therapeutic mechanisms and clinical efficacy of these TCM approaches.</div></div><div><h3>Results</h3><div>Studies highlight the ability of Traditional Chinese Medicine (TCM) herbs to protect and restore muscles through their anti-inflammatory, antioxidant, and metabolic regulatory properties. Investigations have demonstrated improvements in muscle strength, function, and patient outcomes. TCM showed potential supplementary benefits when integrated with standard medical approaches.</div></div><div><h3>Discussion</h3><div>Traditional Chinese Medicine (TCM) offers a comprehensive strategy for addressing myopathy, showing encouraging outcomes in enhancing muscle function and patient well-being. However, despite its potential benefits, there are still obstacles to overcome regarding consistency, risk management, and scientific verification. Additional studies are required to effectively incorporate TCM into established treatment protocols.</div></div>","PeriodicalId":101013,"journal":{"name":"Pharmacological Research - Modern Chinese Medicine","volume":"14 ","pages":"Article 100557"},"PeriodicalIF":0.0,"publicationDate":"2024-12-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143138010","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hepatoprotective activity of Alstonia boonei (De Wild) stem bark in isoniazid-induced Wistar rats: Antioxidant, anti-inflammatory and in silico evaluations
Pub Date : 2024-12-08 DOI: 10.1016/j.prmcm.2024.100558
Adedotun F. Adesina , Joseph T. Apata , Olusegun O. Babalola , Chiagoziem A. Otuechere , Mukaila B. Adekola , Gbenga S. Ogunleye , Funke Asaolu
<div><h3>Introduction</h3><div>Liver damage is mainly caused by exposure to toxic chemicals and is a global health challenge. A variety of <em>Alstonia</em> species including <em>Alstonia boonei</em> has been used in Traditional Chinese Medicines (TCM) for the treatment of fever, asthma and as analgesics. In this research, the potential of <em>A. boonei</em> stem bark ethanol extract and ethyl acetate fraction in restoring isoniazid-induced hepatic damage in rats was studied using antioxidative and anti-inflammatory mechanisms.</div></div><div><h3>Methods</h3><div><em>A. boonei</em> stem bark was extracted with ethanol and fractionated with n-hexane, ethyl acetate, and butanol. <em>In vitro</em> phytochemical screening and quantification, DPPH, ferrous ion chelating and ferric reducing antioxidant activity of the extracts were carried out. Determination of erythrocyte membrane stabilizing and inhibition of protein denaturation activity of the extracts and fractions were used to evaluate anti-inflammatory activity. Gas chromatography- mass spectrometry (GCMS) of the most active fraction was analyzed. A total of 18 and 35 (7 groups of 5) rats were used for both acute and sub-chronic toxicity studies respectively for a period of 60 days. The control group received normal saline, while 15 mg/kg isoniazid (INH) was used to induce liver toxicity. 25, 50 and 100 mg/kg ethyl acetate fractions (EAF), 50 mg/kg of ethanolic extract and 50 mg/kg vitamin C were used as treatment against INH-induced toxicity. The rats were sacrificed and plasma and liver tissues were obtained for biochemical and histological analyses. Plasma markers of hepatic function including alanine aminotransferase (ALT), aspartate amino transferase (AST), lactate dehydrogenase (LDH), gamma-glutamyl transferase (GGT), albumin and bilirubin levels were determined. Activity of Liver enzyme antioxidants including superoxide dismutase (SOD) and catalase were also analyzed. Liver tissues were further subjected to histological analyses. <em>In silico</em> molecular docking and ADMET studies were used to analyze the binding interactions with arginase 1 and thioredoxin reductase and physicochemical properties of the GC–MS identified compounds.</div></div><div><h3>Results</h3><div>Phytochemicals including alkaloids, flavonoids and phenols were present in the plant's extract and fractions, while they also demonstrated antioxidant activity against DPPH radicals, and ferrous ion, with the ethyl acetate fraction possessing the highest antioxidant and anti-inflammatory activity. The ethanolic extract and ethyl acetate fraction of <em>A. boonei</em> stem bark demonstrated significant reductions in the elevated levels of plasma liver function enzymes and were also able to significantly restore the activities of enzyme antioxidants (SOD and catalase). Furthermore, restorations in liver histoarchitecture were observed in groups treated with the extract and fractions. <em>In silico</em> analysis revealed hi
{"title":"Hepatoprotective activity of Alstonia boonei (De Wild) stem bark in isoniazid-induced Wistar rats: Antioxidant, anti-inflammatory and in silico evaluations","authors":"Adedotun F. Adesina ,&nbsp;Joseph T. Apata ,&nbsp;Olusegun O. Babalola ,&nbsp;Chiagoziem A. Otuechere ,&nbsp;Mukaila B. Adekola ,&nbsp;Gbenga S. Ogunleye ,&nbsp;Funke Asaolu","doi":"10.1016/j.prmcm.2024.100558","DOIUrl":"10.1016/j.prmcm.2024.100558","url":null,"abstract":"&lt;div&gt;&lt;h3&gt;Introduction&lt;/h3&gt;&lt;div&gt;Liver damage is mainly caused by exposure to toxic chemicals and is a global health challenge. A variety of &lt;em&gt;Alstonia&lt;/em&gt; species including &lt;em&gt;Alstonia boonei&lt;/em&gt; has been used in Traditional Chinese Medicines (TCM) for the treatment of fever, asthma and as analgesics. In this research, the potential of &lt;em&gt;A. boonei&lt;/em&gt; stem bark ethanol extract and ethyl acetate fraction in restoring isoniazid-induced hepatic damage in rats was studied using antioxidative and anti-inflammatory mechanisms.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Methods&lt;/h3&gt;&lt;div&gt;&lt;em&gt;A. boonei&lt;/em&gt; stem bark was extracted with ethanol and fractionated with n-hexane, ethyl acetate, and butanol. &lt;em&gt;In vitro&lt;/em&gt; phytochemical screening and quantification, DPPH, ferrous ion chelating and ferric reducing antioxidant activity of the extracts were carried out. Determination of erythrocyte membrane stabilizing and inhibition of protein denaturation activity of the extracts and fractions were used to evaluate anti-inflammatory activity. Gas chromatography- mass spectrometry (GCMS) of the most active fraction was analyzed. A total of 18 and 35 (7 groups of 5) rats were used for both acute and sub-chronic toxicity studies respectively for a period of 60 days. The control group received normal saline, while 15 mg/kg isoniazid (INH) was used to induce liver toxicity. 25, 50 and 100 mg/kg ethyl acetate fractions (EAF), 50 mg/kg of ethanolic extract and 50 mg/kg vitamin C were used as treatment against INH-induced toxicity. The rats were sacrificed and plasma and liver tissues were obtained for biochemical and histological analyses. Plasma markers of hepatic function including alanine aminotransferase (ALT), aspartate amino transferase (AST), lactate dehydrogenase (LDH), gamma-glutamyl transferase (GGT), albumin and bilirubin levels were determined. Activity of Liver enzyme antioxidants including superoxide dismutase (SOD) and catalase were also analyzed. Liver tissues were further subjected to histological analyses. &lt;em&gt;In silico&lt;/em&gt; molecular docking and ADMET studies were used to analyze the binding interactions with arginase 1 and thioredoxin reductase and physicochemical properties of the GC–MS identified compounds.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Results&lt;/h3&gt;&lt;div&gt;Phytochemicals including alkaloids, flavonoids and phenols were present in the plant's extract and fractions, while they also demonstrated antioxidant activity against DPPH radicals, and ferrous ion, with the ethyl acetate fraction possessing the highest antioxidant and anti-inflammatory activity. The ethanolic extract and ethyl acetate fraction of &lt;em&gt;A. boonei&lt;/em&gt; stem bark demonstrated significant reductions in the elevated levels of plasma liver function enzymes and were also able to significantly restore the activities of enzyme antioxidants (SOD and catalase). Furthermore, restorations in liver histoarchitecture were observed in groups treated with the extract and fractions. &lt;em&gt;In silico&lt;/em&gt; analysis revealed hi","PeriodicalId":101013,"journal":{"name":"Pharmacological Research - Modern Chinese Medicine","volume":"14 ","pages":"Article 100558"},"PeriodicalIF":0.0,"publicationDate":"2024-12-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143138022","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A mechanistic review on Zanthoxylum species for anti-inflammatory and analgesic potentials 花椒属植物抗炎镇痛作用机制综述
Pub Date : 2024-12-01 DOI: 10.1016/j.prmcm.2024.100553
Acharya Balkrishna , Meenakshi Panwar , Sakshi Mishra , Vidushi Kala , Vedpriya Arya , Anurag Dabas

Introduction

In Traditional Chinese Medicine (TCM), Zanthoxylum species are valued for their analgesic and anti-inflammatory effects, relieving pain and controlling inflammation. The study aimed to provide insight into how Zanthoxylum species reduce inflammation and pain by targeting molecular pathways and regulating immune responses.

Methods

A structured literature search on PubMed, ScienceDirect, and Google Scholar using targeted keywords yielded a broad selection of sources, which were refined to include 104 articles and 50 books from 1978 to 2023 based on strict criteria. Data extraction focused on identifying bioactive compounds and synthesizing insights into the therapeutic mechanisms of Zanthoxylum species, particularly the key pathways involved.

Results

Only 13 of the 33 traditionally used species were shown to be effective in analgesic responses, and only two were employed in treating inflammation ailments. In comparison, 18 species were found to have both anti-inflammatory and analgesic properties. Furthermore, 16 species exhibited anti-inflammatory and analgesic potential in various in-vitro/in-vivo studies. Only ten species studied had anti-inflammatory responses, two had analgesic activity, and four had both anti-inflammatory and analgesic responses. Bioactive compounds like zanthoxylumamides, zanthoaustrones C, tetrahydrobungeanol, decarene, and zanthoxylumamide B exhibit anti-inflammatory effects through MyD88, IRF3, MAPK, and NF-κB pathways. Additionally, the alkaloid benzophenanthridine and essential oils from various plant parts provide analgesic effects by reducing writhing and flinching responses.

Discussion

Modern studies support the traditional use of Zanthoxylum species for inflammation and pain, highlighting anti-inflammatory and analgesic effects via key pathways and suggesting further clinical validation for safety and efficacy.
在中医中,花椒属植物因其镇痛、抗炎、镇痛、消炎等作用而受到重视。该研究旨在深入了解花椒属植物如何通过靶向分子途径和调节免疫反应来减轻炎症和疼痛。方法在PubMed、ScienceDirect和b谷歌Scholar上使用目标关键词进行结构化文献检索,得到广泛的来源选择,根据严格的标准,从1978年到2023年,将其细化为104篇文章和50本书。数据提取主要集中在鉴定花椒属植物的生物活性化合物和合成治疗机制,特别是所涉及的关键途径。结果在33种传统使用的药物中,只有13种具有镇痛效果,只有两种用于治疗炎症性疾病。相比之下,发现18种同时具有抗炎和镇痛特性。此外,在各种体外/体内研究中,16种植物表现出抗炎和镇痛的潜力。只有10种具有抗炎反应,2种具有镇痛活性,4种同时具有抗炎和镇痛反应。生物活性化合物如zanthoxylumamide、zanthoaustrones C、tetrahydrobungeanol、decarene和zanthoxylumamide B通过MyD88、IRF3、MAPK和NF-κB通路表现出抗炎作用。此外,生物碱苯并苯胺和各种植物部位的精油通过减少扭动和退缩反应提供镇痛作用。现代研究支持花椒属植物治疗炎症和疼痛的传统用途,强调了通过关键途径的抗炎和镇痛作用,并建议进一步的临床安全性和有效性验证。
{"title":"A mechanistic review on Zanthoxylum species for anti-inflammatory and analgesic potentials","authors":"Acharya Balkrishna ,&nbsp;Meenakshi Panwar ,&nbsp;Sakshi Mishra ,&nbsp;Vidushi Kala ,&nbsp;Vedpriya Arya ,&nbsp;Anurag Dabas","doi":"10.1016/j.prmcm.2024.100553","DOIUrl":"10.1016/j.prmcm.2024.100553","url":null,"abstract":"<div><h3>Introduction</h3><div>In Traditional Chinese Medicine (TCM), <em>Zanthoxylum</em> species are valued for their analgesic and anti-inflammatory effects, relieving pain and controlling inflammation. The study aimed to provide insight into how <em>Zanthoxylum</em> species reduce inflammation and pain by targeting molecular pathways and regulating immune responses.</div></div><div><h3>Methods</h3><div>A structured literature search on PubMed, ScienceDirect, and Google Scholar using targeted keywords yielded a broad selection of sources, which were refined to include 104 articles and 50 books from 1978 to 2023 based on strict criteria. Data extraction focused on identifying bioactive compounds and synthesizing insights into the therapeutic mechanisms of <em>Zanthoxylum</em> species, particularly the key pathways involved.</div></div><div><h3>Results</h3><div>Only 13 of the 33 traditionally used species were shown to be effective in analgesic responses, and only two were employed in treating inflammation ailments. In comparison, 18 species were found to have both anti-inflammatory and analgesic properties. Furthermore, 16 species exhibited anti-inflammatory and analgesic potential in various in-vitro/in-vivo studies. Only ten species studied had anti-inflammatory responses, two had analgesic activity, and four had both anti-inflammatory and analgesic responses. Bioactive compounds like zanthoxylumamides, zanthoaustrones C, tetrahydrobungeanol, decarene, and zanthoxylumamide B exhibit anti-inflammatory effects through MyD88, IRF3, MAPK, and NF-κB pathways. Additionally, the alkaloid benzophenanthridine and essential oils from various plant parts provide analgesic effects by reducing writhing and flinching responses.</div></div><div><h3>Discussion</h3><div>Modern studies support the traditional use of <em>Zanthoxylum</em> species for inflammation and pain, highlighting anti-inflammatory and analgesic effects via key pathways and suggesting further clinical validation for safety and efficacy.</div></div>","PeriodicalId":101013,"journal":{"name":"Pharmacological Research - Modern Chinese Medicine","volume":"13 ","pages":"Article 100553"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142748716","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Understanding Ganoderma lucidum (Curtis) P. Karst's multipronged potential in improving drug delivery methods and its application in the management of prostate cancer
Pub Date : 2024-12-01 DOI: 10.1016/j.prmcm.2024.100554
Salik Abdullah , Vivek Bakshi , Shreya Mukherjee , Sayandip Paul , Haider Ali Mollick , Sk Maksuda , Biplab Debnath

Introduction

Prostate cancer is the second most prevalent form of cancer in males worldwide, representing a significant global health concern and imposing a substantial health consequence. This type of cancer remains "localized" when tumour cells are confined to the prostate or have spread slightly past it (extra-prostatic extension), but have not metastasized to other areas of the body and is considered "advanced" when it progresses to other areas of the body.

Methods

The present review examines the literature relating Ganoderma lucidum to prostate cancer and the development in nanotechnology-based delivery systems. To relate all three and find a link, a thorough search of literature for more than past 3 decades was done on TCM Bank, TCMSP, PubMed, Google Scholar, ResearchGate, Embase, and ScienceDirect with keywords such as ‘Lingzhi', Traditional Chinese Medicine,G. lucidum polysaccharides, role of TCM in prostate cancer.

Results

Conventional cancer treatments might result in significant adverse reactions, making compounds from natural origin a potentially favourable option for cancer therapy. Ganoderma lucidum (G. lucidum), has been extensively utilized in Asian countries for more than two thousand years to promote health and life expectancy. The Shennong's Herbal Classic documented "Chizhi," "Qingzhi," "Heizhi," "Baizhi," "Huangzhi," and "Zizhi." All six varieties of Ganoderma enhance vision, reinforce muscles and bones, bolster renal function, and calm the nerves.Research has established that G. lucidum possesses substantial efficacy in preventing and treating various forms of cancer, including the cancer of the prostate. G. lucidum has demonstrated strong anticancer properties by targeting specific cancer cells, triggering apoptosis, and suppressing tumour growth. Furthermore, formulations utilizing nanotechnology have shown immunomodulatory effects by stimulating the activation of immune cells and improving the body's defence mechanisms.

Conclusion

G. lucidum, in conjunction with the endless possibilities of nanotechnology, offers a promising frontier in the advancement of innovative therapeutic and biological applications for the treatment of prostate cancer. Additional investigation and advancement in this interdisciplinary domain are necessary to fully harness the combined advantages provided by G. Lucidum and nanotechnology, ultimately resulting in groundbreaking advances in healthcare and well-being.
{"title":"Understanding Ganoderma lucidum (Curtis) P. Karst's multipronged potential in improving drug delivery methods and its application in the management of prostate cancer","authors":"Salik Abdullah ,&nbsp;Vivek Bakshi ,&nbsp;Shreya Mukherjee ,&nbsp;Sayandip Paul ,&nbsp;Haider Ali Mollick ,&nbsp;Sk Maksuda ,&nbsp;Biplab Debnath","doi":"10.1016/j.prmcm.2024.100554","DOIUrl":"10.1016/j.prmcm.2024.100554","url":null,"abstract":"<div><h3>Introduction</h3><div>Prostate cancer is the second most prevalent form of cancer in males worldwide, representing a significant global health concern and imposing a substantial health consequence. This type of cancer remains \"localized\" when tumour cells are confined to the prostate or have spread slightly past it (extra-prostatic extension), but have not metastasized to other areas of the body and is considered \"advanced\" when it progresses to other areas of the body.</div></div><div><h3>Methods</h3><div>The present review examines the literature relating <em>Ganoderma lucidum</em> to prostate cancer and the development in nanotechnology-based delivery systems. To relate all three and find a link, a thorough search of literature for more than past 3 decades was done on TCM Bank, TCMSP, PubMed, Google Scholar, ResearchGate, Embase, and ScienceDirect with keywords such as ‘Lingzhi', Traditional Chinese Medicine,<em>G. lucidum</em> polysaccharides, role of TCM in prostate cancer.</div></div><div><h3>Results</h3><div>Conventional cancer treatments might result in significant adverse reactions, making compounds from natural origin a potentially favourable option for cancer therapy. <em>Ganoderma lucidum</em> (<em>G. lucidum</em>), has been extensively utilized in Asian countries for more than two thousand years to promote health and life expectancy. The Shennong's Herbal Classic documented \"Chizhi,\" \"Qingzhi,\" \"Heizhi,\" \"Baizhi,\" \"Huangzhi,\" and \"Zizhi.\" All six varieties of Ganoderma enhance vision, reinforce muscles and bones, bolster renal function, and calm the nerves.Research has established that <em>G. lucidum</em> possesses substantial efficacy in preventing and treating various forms of cancer, including the cancer of the prostate. <em>G. lucidum</em> has demonstrated strong anticancer properties by targeting specific cancer cells, triggering apoptosis, and suppressing tumour growth. Furthermore, formulations utilizing nanotechnology have shown immunomodulatory effects by stimulating the activation of immune cells and improving the body's defence mechanisms.</div></div><div><h3>Conclusion</h3><div><em>G. lucidum</em>, in conjunction with the endless possibilities of nanotechnology, offers a promising frontier in the advancement of innovative therapeutic and biological applications for the treatment of prostate cancer. Additional investigation and advancement in this interdisciplinary domain are necessary to fully harness the combined advantages provided by <em>G. Lucidum</em> and nanotechnology, ultimately resulting in groundbreaking advances in healthcare and well-being.</div></div>","PeriodicalId":101013,"journal":{"name":"Pharmacological Research - Modern Chinese Medicine","volume":"13 ","pages":"Article 100554"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143151049","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Immunomodulatory effect of compound Xuelian capsule on experimental autoimmune myasthenia gravis in mice
Pub Date : 2024-12-01 DOI: 10.1016/j.prmcm.2024.100549
Fukai Gong , Jianhua Wu , Min Jiao , Yalan Ma , Shilei Zhang , Qiming Han , Hongyan Li

Introduction

This study aimed to explore the immunomodulatory effects of Xuelian capsules in experimental autoimmune myasthenia gravis (EAMG) mice.

Methods

Female C57BL/6 mice were immunized with AChR-α subunit R97–116 peptide to induce EAMG. Mice were randomized into five groups: EAMG model (n = 8), prednisone (n = 7), and low-, middle-, and high-dose Xuelian capsule groups (n = 7, 7, 8). Hematological parameters and NLR were assessed using an automatic hematology analyzer. Serum AchR-Ab, IFN-γ, IL-4, IL-10 levels were measured by ELISA. Thymus pathology was evaluated by HE staining. Spleen mRNA levels of TGF-β, IL-17, IL-6, IFN-γ were quantified by qPCR, and spleen cell populations by flow cytometry.

Results

Xuelian capsules significantly reduced the ratio of NLR in peripheral blood, the concentration of AchR-Ab, IFN-γ, and IL-4 in serum, the expression of TGF-β, IL-17, IL-6, and IFN-γ in the spleen, and the proportion of CD4+/IL-4+ and CD4+/IFN-γ+ cells in the spleen, while increasing the concentration of IL-10 in the serum and the proportion of CD4+/Treg cells in the spleen. It also improved pathological changes in the thymus tissue of mice.

Discussion

One of the possible mechanisms of Xuelian capsules in the treatment of myasthenia gravis is to improve the pathological structure of the thymus of EAMG mice by inhibiting inflammatory factors and improving immunity, which then affects the occurrence and development of inflammation to achieve anti-inflammation, thus improving myasthenia gravis (MG).
{"title":"Immunomodulatory effect of compound Xuelian capsule on experimental autoimmune myasthenia gravis in mice","authors":"Fukai Gong ,&nbsp;Jianhua Wu ,&nbsp;Min Jiao ,&nbsp;Yalan Ma ,&nbsp;Shilei Zhang ,&nbsp;Qiming Han ,&nbsp;Hongyan Li","doi":"10.1016/j.prmcm.2024.100549","DOIUrl":"10.1016/j.prmcm.2024.100549","url":null,"abstract":"<div><h3>Introduction</h3><div>This study aimed to explore the immunomodulatory effects of Xuelian capsules in experimental autoimmune myasthenia gravis (EAMG) mice.</div></div><div><h3>Methods</h3><div>Female C57BL/6 mice were immunized with AChR-α subunit R97–116 peptide to induce EAMG. Mice were randomized into five groups: EAMG model (<em>n</em> = 8), prednisone (<em>n</em> = 7), and low-, middle-, and high-dose Xuelian capsule groups (<em>n</em> = 7, 7, 8). Hematological parameters and NLR were assessed using an automatic hematology analyzer. Serum AchR-Ab, IFN-γ, IL-4, IL-10 levels were measured by ELISA. Thymus pathology was evaluated by HE staining. Spleen mRNA levels of TGF-β, IL-17, IL-6, IFN-γ were quantified by qPCR, and spleen cell populations by flow cytometry.</div></div><div><h3>Results</h3><div>Xuelian capsules significantly reduced the ratio of NLR in peripheral blood, the concentration of AchR-Ab, IFN-γ, and IL-4 in serum, the expression of TGF-β, IL-17, IL-6, and IFN-γ in the spleen, and the proportion of CD4+/IL-4+ and CD4+/IFN-γ+ cells in the spleen, while increasing the concentration of IL-10 in the serum and the proportion of CD4+/Treg cells in the spleen. It also improved pathological changes in the thymus tissue of mice.</div></div><div><h3>Discussion</h3><div>One of the possible mechanisms of Xuelian capsules in the treatment of myasthenia gravis is to improve the pathological structure of the thymus of EAMG mice by inhibiting inflammatory factors and improving immunity, which then affects the occurrence and development of inflammation to achieve anti-inflammation, thus improving myasthenia gravis (MG).</div></div>","PeriodicalId":101013,"journal":{"name":"Pharmacological Research - Modern Chinese Medicine","volume":"13 ","pages":"Article 100549"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143151050","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Pharmacological Research - Modern Chinese Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1